威力传动(300904) - 2025年12月16日投资者关系活动记录表
2025-12-16 07:24
证券代码:300904 证券简称:威力传动 银川威力传动技术股份有限公司 投资者关系活动记录表 编号:2025-043 投 资 者 关 系 活 动类别 □特定对象调研 □媒体采访 □新闻发布会 □现场参观 □分析师会议 □业绩说明会 □路演活动 ☑ 其他:线上会议 参 与 单 位 名 称 及人员姓名 信达证券、安信证券、国泰基金、宁银理财、阳光天泓资产 时间 2025 年 12 月 16 日 地点 线上会议 上 市 公 司 接 待 人员姓名 副总裁、董事会秘书周建林先生 投 资 者 关 系 活 动主要内容介绍 一、介绍公司概况 副总裁、董事会秘书周建林先生向与会的机构投资者简要介绍 了公司近期经营情况及增速器智慧工厂项目进展。 二、与投资者沟通和交流的主要问题 1、公司再融资进展情况? 答:公司本次再融资采用向特定对象发行 A 股股票的方式,募 集资金总额不超过 6 亿元(含本数),募集资金扣除相关发行费用 后将用于风电增速器智慧工厂(一期)及补充流动资金。相关工作 正按计划稳步推进。 2025 年 9 月 15 日,公司召开 2025 年第四次临时股东会,审议 通过了《关于公司符合向特定对象发行 A 股股票 ...
久祺股份(300994) - 300994久祺股份投资者关系管理信息20251216
2025-12-16 06:20
附件: 参会人员名单 久祺股份有限公司投资者关系活动记录表 投资者关系活动 类别 □ 特定对象调研 □ 分析师会议 □ 媒体采访 □业绩说明会 □ 新闻发布会 □路演活动 ☑ 现场参观 ☑ 其他 (电话会议) 参与单位名称及 人员姓名 详见附件 时间 2025 年 12 月 13 日-12 月 16 日 地点 久祺股份有限公司会议室 上市公司接待人 员姓名 董秘:雍嬿 证券代表 :陆佳骐 投资者关系活动 主要内容介绍 1、公司黑五电商销售情况如何? 答:公司跨境电商自主品牌 JOYSTAR、CYCMOTO、HILAND 等 在亚马逊平台销量排名前列,黑五销售表现良好。公司会加强产 品设计研发,开发符合消费者喜好的高品质、新设计产品,实现 电商销售的进一步增长。 2、公司产品在亚马逊等海外平台成为爆品的逻辑是什么? 答:公司产品在亚马逊等电商平台销售亮眼的逻辑主要包括: 一是设计款式丰富,产品 SKU 众多,迎合当地消费者需求的同时 给消费者提供更多产品选择;国外很多公司以单款爆品,产品矩 阵不如公司丰富。二是产品价格相比美国当地品牌有竞争优势。 三是亚马逊店铺为自营模式,产品上架速度快、定价自由、款式 丰富。 ...
佐力药业(300181) - 2025年12月12日-2025年12月14日投资者关系活动记录表
2025-12-15 12:59
证券代码:300181 证券简称:佐力药业 编号:2025-017 浙江佐力药业股份有限公司 投资者关系活动记录表 | 投资者关系活动 | □特定对象调研 □分析师会议 | | --- | --- | | 类别 | □媒体采访 □业绩说明会 | | | □新闻发布会 □路演活动 | | | ☑现场参观 | | | ☑其他 (电话会议) | | 参与单位名称及 | 华安证券;国泰海通证券;甬兴证券;中信证券;东吴证券; | | 人员姓名(以上 | 长江医药;光大证券;中信建投;北京岑峰;壹同创业投资; | | | 红杉资本;华鑫国际信托;恒穗资产;大兴华旗;六妙星私募; | | 排名不分先后) | 量利资本;大橡私募;伟晟私募;安徽海富投资;致新资本等。 | | | 荣泽石资产;博远基金;信达证券;江海证券;上海恒穗资产; | | | 泰达宏利;华安证券;建信基金;佳润实业;国投证券;华安 | | | 证券;西部医药;中金资管;国金证券;北京含章私募;宁波 | | | 量利私募;甬兴证券;贵源投资;恒基浦业资管;国源信达资 | | | 本;太平资产;宝盈基金;中融汇信投资;东吴证券;开源证 | | | 券;钧泽 ...
雪人集团(002639) - 002639雪人集团投资者关系活动记录表20251215
2025-12-15 11:30
Group 1: Company Overview - Fujian Snowman Group Co., Ltd. was established in 2000, focusing on thermal power technology for cold chain logistics, industrial refrigeration, clean energy, and hydrogen power sectors [1] - In the first three quarters of 2025, the company achieved a revenue of CNY 1.631 billion, representing a year-on-year increase of 24.26% [1] Group 2: Data Center Business Expansion - The company has entered the data center business through compressor refrigeration equipment supply and key project construction [1] - It offers a diverse product line including piston compressors, open screw compressors, semi-hermetic screw compressors, and centrifugal compressors, with a new centrifugal compressor designed for high-efficiency data centers now on the market [1] - The company utilizes low-charge ammonia refrigeration technology, replacing traditional refrigerants, exemplified by its provision of third-generation low-charge ammonia cooling technology to Facebook's Denmark data center [1][2] Group 3: Controlled Nuclear Fusion Business - The company produces helium compressors essential for large-scale low-temperature systems, crucial for projects like the superconducting tokamak [2] - Its "megawatt-level" helium compressors can achieve cooling capacities at -271°C, with the technology recognized as internationally leading [2] Group 4: Hydrogen Energy Sector - The company is developing hydrogen fuel cell technology, focusing on core components and systems, while extending its existing compressor and refrigeration technologies to liquid hydrogen applications [2] - It has established a global hydrogen fuel cell technology R&D and supply chain system, with research institutions in Europe and Japan [2] - The new generation of metal plate fuel cell stacks has been developed, and the company is advancing the mass production of hydrogen fuel cells and core components domestically [2]
视觉中国(000681) - 投资者关系管理信息
2025-12-15 11:26
Group 1: Business Collaborations and Revenue Generation - The company has secured compliance data service business orders from major domestic and international AI model companies, including Alibaba, Tencent, and Microsoft, for model training purposes [2] - The company is a primary supplier of multimodal data for Tencent's mixed Yuan model and has established a partnership with Microsoft that includes both compliance data for exclusive model training and copyright material integration [2] - The company has launched a creative ToB custom service platform that integrates with top global models like Midjourney and nanobanana, facilitating various content generation services [2] Group 2: Data Resources and Industry Position - The company possesses over 700 million high-quality, copyright-compliant content data for AI model training, leading the industry [4] - It has a comprehensive structured metadata system with 3 million structured tags and industry knowledge graphs, providing a solid foundation for compliant training and commercial applications [4] - The company emphasizes that the demand for high-quality copyright data will continue to grow as AI models evolve, positioning itself as a key player in the generative AI value chain [4] Group 3: Content Monetization and IP Management - The company is actively exploring IP revenue-sharing models in collaboration with major platforms, recognizing the importance of high-quality compliant content for monetization opportunities [4][5] - Strategic partnerships have been established with platforms like Vidu and Jianying, allowing the company to provide authorized content to users beyond the Jianying platform [4] - The company aims to enhance its collaboration with generative AI platforms to explore IP licensing management and content revenue-sharing models [5]
周大生(002867) - 2025年12月15日投资者关系活动记录表
2025-12-15 11:24
Group 1: Investor Relations Activity Overview - The investor relations activity involved a specific audience survey with three investors participating: Jianxin Pension (Tao Jin, Cao Jingyi) and Changjiang Securities (Li Jin) [2] - The meeting took place on December 15, 2025, at the company's headquarters [2] - Company representatives included Chairman and General Manager Zhou Zongwen, Board Secretary and Deputy General Manager He Xiaolin, and Securities Affairs Representative Rong Huan [2] Group 2: Key Discussion Topics - Investors inquired about industry conditions, brand matrix, national treasures, product structure, terminal sales performance, and dividend planning [2] - The company ensured compliance with the Information Disclosure Management System, maintaining the accuracy, completeness, and timeliness of disclosed information [2] - Investors signed a commitment letter as per Shenzhen Stock Exchange requirements during the on-site survey [2]
博盈特焊(301468) - 2025年12月15日投资者关系活动记录表
2025-12-15 10:58
Company Overview - Guangdong Boying Special Welding Technology Co., Ltd. was established in 2007, initially focusing on welding services for offshore drilling platforms for North American clients. The company has since expanded into anti-corrosion and wear-resistant welding fields and successfully listed on the Shenzhen Stock Exchange's Growth Enterprise Market in July 2023 [1]. - The company emphasizes advanced welding technology and provides manufacturing services and process solutions to clients [1]. Market Strategy - The company aims to maintain its leading position in the domestic market while actively exploring overseas markets, particularly by investing in a production base in Vietnam to seize opportunities in the North American HRSG market [1]. - The demand for waste incineration and the transformation of the coal-fired power generation industry are expected to enhance market penetration rates, with significant growth potential in chemical, metallurgy, and paper industries [1]. Business Development - The company has proactively laid out HRSG and oil-gas composite pipe businesses, with HRSG already achieving a certain scale of production and securing some orders. Potential clients are currently undergoing factory audits [2]. - The new production base in Vietnam has commenced operations, with a second phase under construction. The Dawa production base is also progressing, expected to be operational next year [2]. Competitive Landscape - In the Vietnamese HRSG market, competitors include manufacturers from South Korea, Thailand, and Vietnam. The company has extensive experience in the energy sector and has established a production line in Vietnam, providing a cost advantage over foreign competitors [3]. - The production cycle for HRSG products is approximately six months, with the Vietnam base primarily producing components for gas turbine heat recovery systems [3][4]. Production Capacity - One HRSG production line in Vietnam can produce about two sets of HRSG devices per year, depending on production scheduling and resource availability [4]. - The company has obtained necessary certifications, including ASME, and is progressing well in the customer audit process for entering the North American market [5]. Industry Applications - The company's main business includes anti-corrosion and wear-resistant welding equipment, non-welded boiler components, pressure vessels, and high-end steel structures, applicable in energy, chemical, metallurgy, and paper industries [6][7]. - The company has established relationships with high-quality clients in various sectors, including paper and metallurgy, further solidifying its leading position in the industrial anti-corrosion and wear-resistant market [6].
云南白药(000538) - 2025年12月12日投资者关系活动记录表(一)
2025-12-15 10:56
Group 1: Investor Relations Activity - The meeting was categorized as a specific object survey [2] - Participants included representatives from Shenzhen Century Quantum and various other individuals [2] - The meeting took place on December 12, 2025, at the company's headquarters [2] Group 2: Purpose of the Meeting - The main objective was to understand the company's production and operational status [2]
云南白药(000538) - 2025年12月12日投资者关系活动记录表(二)
2025-12-15 10:56
云南白药集团股份有限公司 1 / 1 投资者调研会议记录表 编号:40-2512-05 投资者关系活动类别 ☑ 特定对象调研 □分析师会议 □媒体采访 □业绩说明会 □新闻发布会 □路演活动 ☑ 现场参观 □一对一沟通 □其他(电话会议) 参与单位名称及人员 姓名 红思客资产、广州顺从投资、深圳奇创集团等机构及个人投资 者 32 人 时间 2025 年 12 月 12 日 地点 集团总部办公大楼 上市公司接待人员 投资者关系管理-张昱、杨可欣 投资者关系活动主要 内容介绍 了解公司生产经营情况 附件清单 会议记录 日期 2025 年 12 月 12 日星期五 ...
云南白药(000538) - 2025年12月12日调研活动附件之投资者调研会议记录(二)
2025-12-15 10:56
Group 1: Pharmaceutical Business Performance - In the first half of 2025, the pharmaceutical business group achieved a main business revenue of CNY 4.751 billion, a year-on-year increase of 10.8% [2] - Sales revenue of Yunnan Baiyao aerosol exceeded CNY 1.453 billion, with a significant year-on-year growth of over 20.9% [2] - Other traditional Chinese medicine products showed remarkable growth, with sales of Canling Jianpi Granules exceeding CNY 100 million and Pudilan Anti-inflammatory Tablets nearing CNY 100 million [2] Group 2: Online Sales and Marketing - The pharmaceutical business group expanded its online market, with O2O sales increasing by over 20% year-on-year [3] - During the 2025 "618" shopping festival, the company’s main products ranked significantly higher on the regular medicine list [3] - E-commerce platforms attracted 48.45 million visitors, resulting in 3.54 million consumers and generating a GMV of CNY 254 million [3] Group 3: Health Products Strategy - The health products group aims to become a leader in high-quality health lifestyle products, focusing on oral care and hair care [4] - Continuous enhancement of oral product advantages and rapid scaling of hair care business are key objectives for the second half of the year [4] Group 4: Nuclear Medicine Development - The INR101 diagnostic nuclear medicine project has initiated Phase III clinical trials, with 32 research centers established and 60 subjects enrolled [5] - The INR102 therapeutic nuclear medicine project has received clinical trial approval, with 12 patients enrolled in Phase I trials [5] Group 5: Traditional Chinese Medicine Resource Development - The Chinese medicine resource group focuses on Yunnan's local medicinal materials, achieving significant results through collaborative efforts [6] - The establishment of 14 seed source bases and the completion of 90% of the annual target for quality seed promotion [6] - The digital cloud medicine platform achieved a transaction volume exceeding CNY 1 billion, with 18,000 registered farmers [6] Group 6: Future Directions for Provincial Pharmaceutical Company - The provincial pharmaceutical company plans to enhance market share in existing hospitals and distribution channels while exploring new growth areas [8] - Strategies include optimizing supply chain management and improving accounts receivable and inventory structure [8]